178
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Protective effects of atorvastatin against high glucose-induced nuclear factor-κB activation in cultured C28I2 chondrocytes

, ORCID Icon & ORCID Icon
Pages 1-8 | Received 06 May 2018, Accepted 03 Dec 2018, Published online: 25 Jun 2019

References

  • Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum. 2008;58:26–35.
  • McDougall JJ. Arthritis and pain. Neurogenic origin of joint pain. Arthritis Res Ther. 2006;8:220.
  • Jiang L, Ma A, Song L, et al. Cartilage regeneration by selected chondrogenic clonal mesenchymal stem cells in the collagenase‐induced monkey osteoarthritis model. J Tissue Eng Regen Med. 2014;8:896–905.
  • Hosseinzadeh A, Bahrampour Juybari K, Fatemi MJ, et al. Protective effect of ginger (Zingiber officinale Roscoe) extract against oxidative stress and mitochondrial apoptosis induced by interleukin-1β in cultured chondrocytes. Cells Tissues Organs. 2017;204:241–250.
  • Hosseinzadeh A, Jafari D, Kamarul T, et al. Evaluating the protective effects and mechanisms of Diallyl disulfide on interlukin-1β-induced oxidative stress and mitochondrial apoptotic signaling pathways in cultured chondrocytes . J Cell Biochem. 2017;118:1879–1888.
  • Nieves-Plaza M, Castro-Santana LE, Font YM, et al. Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico. J Clin Rheumatol: Pract Rep Rheum Musculoskelet Dis. 2013;19:1–6.
  • Marshall M, Peat G, Nicholls E, et al. Subsets of symptomatic hand osteoarthritis in community-dwelling older adults in the United Kingdom: prevalence, inter-relationships, risk factor profiles and clinical characteristics at baseline and 3-years. Osteoarthritis Cartilage. 2013;21:1674–1684.
  • Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad Med J. 2012;88:240–242.
  • Chen Y-J, Chan D-C, Lan K-C, et al. PPARγ is involved in the hyperglycemia‐induced inflammatory responses and collagen degradation in human chondrocytes and diabetic mouse cartilages. J Orthop Res. 2015;33:373–381.
  • Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol. 2006;20:1003–1025.
  • Verzijl N, Bank RA, TeKoppele JM, et al. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol. 2003;15:616–622.
  • Gillery P. Oxidative stress and protein glycation in diabetes mellitus. Ann Biol Clin. 2006;64(4):309–314.
  • Asakawa H, Miyagawa J-I, Hanafusa T, et al. High glucose and hyperosmolarity increase secretion of interleukin-1 β in cultured human aortic endothelial cells. J Diabetes Complications. 1997;11:176–179.
  • Askwith T, Zeng W, Eggo MC, et al. Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells. Exp Neurol. 2012;233:154–162.
  • Jia J, Liu Y, Zhang X, et al. Regulation of iNOS expression by NF-κB in human lens epithelial cells treated with high levels of glucoseNF-κB in human LECs treated with glucose. Invest Ophthalmol Vis Sci. 2013;54:5070–5077.
  • Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes. 2008;57:1952–1965.
  • Yao D, Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes. 2010;59:249–255.
  • Rosa SC, Rufino AT, Judas FM, et al. Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes. J Cell Biochem. 2011;112:2813–2824.
  • Rasheed Z, Haqqi TM. Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes. Biochim Biophys Acta (BBA)-Mol Cell Res. 2012;1823:2179–2189.
  • Nah S-S, Choi I-Y, Lee CK, et al. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology. 2008;47:425–431.
  • Chen YJ, Sheu ML, Tsai KS, et al. Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products. PLoS One. 2013;8:e66611.
  • Steenvoorden M, Huizinga TW, Verzijl N, et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum. 2006;54:253–263.
  • Mendes AF, Carvalho AP, Caramona MM, et al. Role of nitric oxide in the activation of NF-? B, AP-1 and NOS II expression in articular chondrocytes. Inflamm Res. 2002;51:369–375.
  • Acharjee S, Welty FK. Atorvastatin and cardiovascular risk in the elderly–patient considerations. Clin Interv Aging. 2008;3:299.
  • DuBroff R, de Lorgeril M. Cholesterol confusion and statin controversy. World J Cardiol. 2015;7:404.
  • Blanco-Colio LM, Tuñón J, Martín-Ventura JL, et al. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 2003;63:12–23.
  • Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord. 2013;6:19–33.
  • Shavakhi A, Minakari M, Bighamian A, et al. Statin efficacy in the treatment of hepatitis C genotype I. J Res Med Sci: Off J Isfahan Univ Med Sci. 2014;19:S1.
  • Eslami L, Merat S, Malekzadeh R, et al. Statins for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis. Cochrane Library. 2013;(12):CD008623.
  • Takemoto M, Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest. 2001;108:1429.
  • van de Ree MA, Huisman MV, Princen HMG, et al. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis. 2003;166:129–135.
  • Everett BM, Mora S Glynn RJ, et al. Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (< 30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER. ). Am J Cardiol. 2014;114:1682–1689.
  • Bedi O, Dhawan V, Sharma PL, et al. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn-Schmiedeberg’s Arch Pharmacol. 2016;389:695–712.
  • Barsante MM, Roffê E, Yokoro CM, et al. Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. Eur J Pharmacol. 2005;516:282–289.
  • Dichtl W, Dulak J, Frick M, et al. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2003;23:58–63.
  • Goldring MB. Culture of immortalized chondrocytes and their use as models of chondrocyte function. Methods Mol Med. 2004;100:37–52.
  • Juybari KB, Kamarul T, Najafi M, et al. Restoring the IL-1β/NF-κB-induced impaired chondrogenesis by diallyl disulfide in human adipose-derived mesenchymal stem cells via attenuation of reactive oxygen species and elevation of antioxidant enzymes. Cell Tissue Res. 2018;373:407–419.
  • Courties A, Gualillo O, Berenbaum F, et al. Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage. 2015;23:1955–1965.
  • Gerlag DM, Ransone L, Tak PP, et al. The effect of a T cell-specific NF-κB inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol. 2000;165:1652–1658.
  • Li L, Liu H, Shi W, et al. Insights into the action mechanisms of traditional Chinese medicine in osteoarthritis. Evid Based Complement Alternat Med. 2017;2017:5190986.
  • Wu L, Liu H, Li L, et al. Mitochondrial pathology in osteoarthritic chondrocytes. Cdt. 2014;15:710–719.
  • Olivotto E, Otero M, Marcu KB, et al. Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiation. RMD Open. 2015;1:e000061.
  • Rashidian A, Muhammadnejad A, Dehpour A-R, et al. Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacology. 2016;24:109–118.
  • Wang Y, Zhang MX, Meng X, et al. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells. Am J Physiol-Heart Circ Physiol. 2011;300:H1743–H1752.
  • Calisto KL, Carvalho BdM, Ropelle ER, et al. Atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling. PLoS One. 2010;5:e14232.
  • King K, Rosenthal A. The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms. Osteoarthritis Cartilage. 2015;23:841–850.
  • Laiguillon M-C, Courties A, Houard X, et al. Cartilage in the context of hyperglycemia and diabetes: further pathophysiological clues for diabetes-related osteoarthritis. Osteoarthritis Cartilage. 2015;23:A293.
  • Silberberg R, Hirshberg G, Lesker P. Enzyme studies in the articular cartilage of diabetic rats and of rats bearing transplanted pancreatic islets. Diabetes. 1977;26:732–735.
  • Umpierrez GE, Zlatev T, Spanheimer RG. Correction of altered collagen metabolism in diabetic animals with insulin therapy3. Matrix. 1989;9:336–342.
  • Kelley KM, Johnson TR, Ilan J, et al. Glucose regulation of the IGF response system in chondrocytes: induction of an IGF-I-resistant state. Am J Physiol-Regul Integr Comp Physiol. 1999;276:R1164–R1171.
  • Rufino A, Ribeiro M, Judas F, et al. A5. 1 Culture of human chondrocytes in high glucose induces inflammatory markers and impairs autophagy. Ann Rheum Dis. 2014;73:A63.
  • Wang Y, Tonkin A, Jones G, et al. Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? Study protocol for a randomised controlled trial. Trials. 2015;16:584.
  • Baker JF, Walsh P, Mulhall KJ. Statins: a potential role in the management of osteoarthritis? Joint Bone Spine. 2011;78:31–34.
  • Bayyurt S, Kucukalp A, Bilgen MS, et al. The chondroprotective effects of intraarticular application of statin in osteoarthritis: an experimental study. Indian J Orthop. 2015;49:665.
  • Simopoulou T, Malizos KN, Poultsides L, et al. Protective effect of atorvastatin in cultured osteoarthritic chondrocytes. J Orthop Res. 2010;28:110–115.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.